Creative Planning’s Altimmune ALT Stock Holding History
Bought
Maintained
Sold
Other funds holding ALT
VCM
VPM
N
Creative Planning's ALT Position: Q1 2026 in Review
Creative Planning reduced its Altimmune (ALT) stake by 16% in Q1 2026, selling an estimated $32.5K and leaving 39,229 shares worth $121K. The position accounts for ﹤0.01% of the portfolio, ranked #3859.
Creative Planning first reported a position in ALT in Q1 2014 and has held it in 21 quarters since. The position peaked at $342K in Q3 2020. 173 funds tracked by Wall St. Rank hold ALT as of Q1 2026.
- Creative Planning held 39,229 shares of Altimmune worth $121K as of Q1 2026.
- Creative Planning sold 7,657 Altimmune shares in Q1 2026, an estimated $32.5K.
- Altimmune made up ﹤0.01% of Creative Planning's portfolio in Q1 2026, its #3859 holding.
- Creative Planning first reported a position in Altimmune in Q1 2014 and has held it in 21 quarters since.
- Creative Planning's Altimmune position peaked at $342K in Q3 2020.
- 173 funds tracked by Wall St. Rank held Altimmune as of Q1 2026.
Based on Creative Planning's 13F filing for Q1 2026, filed 12 May 2026.